FDA Clears More Devices in H1 2026 But Timelines Slip

The US Food and Drug Administration authorised more medical devices in the first half of 2026 than in the same period last year, but average time to approval has lengthened materially across every major pathway. Reported on 1 July 2026 by MedTech Dive from a BTIG research note, the data highlights a growing tension between the FDA’s clearance volumes and the timing pressure faced by manufacturers, particularly smaller companies.

The premarket approval pathway, the FDA’s most stringent evaluation route for high-risk devices, saw 23 authorisations through June, up 10 from the same period last year. Average time to PMA approval reached nearly 599 days in H1 2026 versus around 402 days over the same period in 2025, though BTIG flagged a small number of outliers as significant contributors to the extended average. The 510(k) pathway saw 1,669 clearances through June, a 2.5% year-on-year increase, with average time to decision extending by seven to eight days to around 156 days.

The de novo pathway remained flat at 14 classifications, though time to approval increased by just over 8%. Panel track approvals, which cover significant design changes or new indications for existing devices, rose nearly 17% but with 6.5% longer average review times. BTIG analyst Ryan Zimmerman noted that while the increase in authorisations is encouraging, timing carries more weight for smaller device developers where capital runway and demand forecasting depend on regulatory certainty. Behind the numbers, the FDA’s device centre continues to face capacity pressure that is contributing to the timing slippage across pathways.

The commercial signal is that regulatory pathway timing has become as important as pathway success. For smaller medical device developers where each additional review month erodes capital runway, the widening gap between authorisation volume and speed is the more consequential trend. Expect increased premium on regulatory strategy and clinical evidence quality as timelines drift longer.

For the latest updates and in-depth insights into the world of Medical Devices, including breakthrough treatments, industry trends, and regulatory news, contact Albert Baines today!